PUBLISHER: TechNavio | PRODUCT CODE: 1915647
PUBLISHER: TechNavio | PRODUCT CODE: 1915647
Global AI In Pharma And Biotech Market 2025-2029
The global AI in pharma and biotech market is forecasted to grow by USD 3632.4 mn during 2024-2029, accelerating at a CAGR of 20.0% during the forecast period. The report on the global AI in pharma and biotech market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative to overcome declining research and development productivity and escalating costs, exponential growth of biomedical data and availability of high-performance computing, increasing investment, strategic collaborations, and validating success stories.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 18.2% |
| CAGR | 20% |
| Incremental Value | $3632.4 mn |
Technavio's global AI in pharma and biotech market is segmented as below:
By Type
- Small molecules
- Large molecules
- Vaccines
- Cell and gene therapies
By Technology
- Machine learning
- Deep learning
- NLP
- Computer vision
- Generative AI
By Application
- Drug discovery
- Preclinical and clinical trials
- Regulatory compliance and pharmacovigilance
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- The Netherlands
- Italy
- Spain
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- South America
- Brazil
- Argentina
- Colombia
- Middle East and Africa
- UAE
- South Africa
- Turkey
- Rest of World (ROW)
This study identifies the industrialization of discovery through scalable, ai-powered research and development platforms as one of the prime reasons driving the global AI in pharma and biotech market growth during the next few years. Also, ai-driven biomarker discovery and scaling of precision medicine and increasing integration of AI with real-world evidence and clinical trial modernization will lead to sizable demand in the market.
The report on the global AI in pharma and biotech market covers the following areas:
- Global AI in pharma and biotech market sizing
- Global AI in pharma and biotech market forecast
- Global AI in pharma and biotech market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global AI in pharma and biotech market vendors that include Aria Intelligent Solutions, Arzeda Corp., Atomwise Inc., Auransa Inc., BenevolentAI, BioAge Labs Inc., Cloud Pharmaceuticals Inc., Deep Genomics Inc., Exscientia plc, Healx Ltd., Insilico Medicine, Owkin Inc., PathAI Inc., Recursion Pharmaceuticals Inc., Schrodinger Inc., Turbine Ltd., Valo Health, Verge Analytics Inc., Shenzhen Jingtai Technology Co.Ltd. Also, the global AI in pharma and biotech market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
5 Historic Market Size
- 5.1 Global AI In Pharma And Biotech Market 2019 - 2023
- Historic Market Size - Data Table on Global AI In Pharma And Biotech Market 2019 - 2023 ($ million)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.3 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
- 5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Five Forces Analysis
- 6.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 6.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 6.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 6.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 6.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 6.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 6.7 Market condition
7 Market Segmentation by Type
- 7.1 Market segments
- 7.2 Comparison by Type
- 7.3 Small molecules - Market size and forecast 2024-2029
- 7.4 Large molecules - Market size and forecast 2024-2029
- 7.5 Vaccines - Market size and forecast 2024-2029
- 7.6 Cell and gene therapies - Market size and forecast 2024-2029
- 7.7 Market opportunity by Type
- Market opportunity by Type ($ million)
8 Market Segmentation by Technology
- 8.1 Market segments
- 8.2 Comparison by Technology
- 8.3 Machine learning - Market size and forecast 2024-2029
- 8.4 Deep learning - Market size and forecast 2024-2029
- 8.5 NLP - Market size and forecast 2024-2029
- 8.6 Computer vision - Market size and forecast 2024-2029
- 8.7 Generative AI - Market size and forecast 2024-2029
- 8.8 Market opportunity by Technology
- Market opportunity by Technology ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Drug discovery - Market size and forecast 2024-2029
- 9.4 Preclinical and clinical trials - Market size and forecast 2024-2029
- 9.5 Regulatory compliance and pharmacovigilance - Market size and forecast 2024-2029
- 9.6 Others - Market size and forecast 2024-2029
- 9.7 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- 11.2 Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- 11.3.1 US - Market size and forecast 2024-2029
- 11.3.2 Canada - Market size and forecast 2024-2029
- 11.3.3 Mexico - Market size and forecast 2024-2029
- 11.4 Europe - Market size and forecast 2024-2029
- 11.4.1 Germany - Market size and forecast 2024-2029
- 11.4.2 UK - Market size and forecast 2024-2029
- 11.4.3 France - Market size and forecast 2024-2029
- 11.4.4 The Netherlands - Market size and forecast 2024-2029
- 11.4.5 Italy - Market size and forecast 2024-2029
- 11.4.6 Spain - Market size and forecast 2024-2029
- 11.5 APAC - Market size and forecast 2024-2029
- 11.5.1 China - Market size and forecast 2024-2029
- 11.5.2 Japan - Market size and forecast 2024-2029
- 11.5.3 India - Market size and forecast 2024-2029
- 11.5.4 South Korea - Market size and forecast 2024-2029
- 11.5.5 Australia - Market size and forecast 2024-2029
- 11.5.6 Indonesia - Market size and forecast 2024-2029
- 11.6 South America - Market size and forecast 2024-2029
- 11.6.1 Brazil - Market size and forecast 2024-2029
- 11.6.2 Argentina - Market size and forecast 2024-2029
- 11.6.3 Colombia - Market size and forecast 2024-2029
- 11.7 Middle East and Africa - Market size and forecast 2024-2029
- 11.7.1 Saudi Arabia - Market size and forecast 2024-2029
- 11.7.2 UAE - Market size and forecast 2024-2029
- 11.7.3 South Africa - Market size and forecast 2024-2029
- 11.7.4 Turkey - Market size and forecast 2024-2029
- 11.7.5 Israel - Market size and forecast 2024-2029
- 11.8 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
12 Drivers, Challenges, and Opportunity
- 12.1 Market drivers
- Imperative to overcome declining research and development productivity and escalating costs
- Exponential growth of biomedical data and availability of high-performance computing
- Increasing investment, strategic collaborations, and validating success stories
- 12.2 Market challenges
- Data quality, accessibility, and governance challenges
- High cost of implementation and scarcity of specialized talent
- Regulatory uncertainty and black box problem
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities
- Industrialization of discovery through scalable, AI-powered research and development platforms
- AI-driven biomarker discovery and scaling of precision medicine
- Increasing integration of AI with real-world evidence and clinical trial modernization
13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.1 Companies profiled
- Companies covered
- 14.2 Company ranking index
- Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Aria Intelligent Solutions
- Aria Intelligent Solutions - Overview
- Aria Intelligent Solutions - Product / Service
- Aria Intelligent Solutions - Key offerings
- SWOT
- 14.5 Auransa Inc.
- Auransa Inc. - Overview
- Auransa Inc. - Product / Service
- Auransa Inc. - Key offerings
- SWOT
- 14.6 BenevolentAI
- BenevolentAI - Overview
- BenevolentAI - Product / Service
- BenevolentAI - Key offerings
- SWOT
- 14.7 BioAge Labs Inc.
- BioAge Labs Inc. - Overview
- BioAge Labs Inc. - Product / Service
- BioAge Labs Inc. - Key offerings
- SWOT
- 14.8 Cloud Pharmaceuticals Inc.
- Cloud Pharmaceuticals Inc. - Overview
- Cloud Pharmaceuticals Inc. - Product / Service
- Cloud Pharmaceuticals Inc. - Key offerings
- SWOT
- 14.9 Exscientia plc
- Exscientia plc - Overview
- Exscientia plc - Product / Service
- Exscientia plc - Key offerings
- SWOT
- 14.10 Insilico Medicine
- Insilico Medicine - Overview
- Insilico Medicine - Product / Service
- Insilico Medicine - Key offerings
- SWOT
- 14.11 Owkin Inc.
- Owkin Inc. - Overview
- Owkin Inc. - Product / Service
- Owkin Inc. - Key offerings
- SWOT
- 14.12 PathAI Inc.
- PathAI Inc. - Overview
- PathAI Inc. - Product / Service
- PathAI Inc. - Key offerings
- SWOT
- 14.13 Recursion Pharmaceuticals Inc.
- Recursion Pharmaceuticals Inc. - Overview
- Recursion Pharmaceuticals Inc. - Product / Service
- Recursion Pharmaceuticals Inc. - Key offerings
- SWOT
- 14.14 Schrodinger Inc.
- Schrodinger Inc. - Overview
- Schrodinger Inc. - Business segments
- Schrodinger Inc. - Key offerings
- Schrodinger Inc. - Segment focus
- SWOT
- 14.15 Turbine Ltd.
- Turbine Ltd. - Overview
- Turbine Ltd. - Product / Service
- Turbine Ltd. - Key offerings
- SWOT
- 14.16 Valo Health
- Valo Health - Overview
- Valo Health - Product / Service
- Valo Health - Key offerings
- SWOT
- 14.17 Verge Analytics Inc.
- Verge Analytics Inc. - Overview
- Verge Analytics Inc. - Product / Service
- Verge Analytics Inc. - Key offerings
- SWOT
- 14.18 Shenzhen Jingtai Technology Co.Ltd
- Shenzhen Jingtai Technology Co.Ltd - Overview
- Shenzhen Jingtai Technology Co.Ltd - Product / Service
- Shenzhen Jingtai Technology Co.Ltd - Key offerings
- SWOT
15 Appendix
- 15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- Research methodology
- 15.5 Data procurement
- Information sources
- 15.6 Data validation
- Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
- List of abbreviations
